Myriad Logo
  • Patients
    • I need help with…
      • Understanding hereditary cancer riskWhat is my risk of developing hereditary cancer?
      • Treating cancerWhat are my treatment options?
      • Prenatal careIs my baby at risk for a genetic condition?
      • Managing mental healthHow might my genes affect my medication outcomes?
    • (sidebar parent)
      • About genetic testing
        • What are the costs of genetic testing?
        • Financial assistance
      • Patient Resources
        • How does genetic testing work?
        • Patient record request
      • Prostate Cancer
        • What are my treatment options?
  • Providers
    • My patient needs a test for…
      • Assessing hereditary cancer riskWhat is my patient’s risk of developing hereditary cancer?
      • Cancer treatmentWhat is the best treatment for my patient?
      • Prenatal careWhat is a pregnancy’s risk of genetic disease?
      • Mental health treatmentHow will my patient metabolize or respond to certain medications?
    • (sidebar parent)
      • About our tests
        • Myriad test catalog
        • Research & whitepapers
        • MyRisk™ gene table
      • Provider resources
        • Order a test
        • Documents & forms
        • Scope of service & lab certificates
      • Prostate Cancer Treatment
        • What are my patient’s treatment options?
  • Our Tests
    • Tests for…
      • (column wrapper)
        • Prenatal care
          • Chromosome conditions
          • Genetic diseases
        • Cancer risk assessment
          • Hereditary cancer
        • Mental health
          • Depression
          • Anxiety
          • ADHD
      • (column wrapper)
        • Cancer management
          • Breast cancer
          • Ovarian cancer
          • Pancreatic cancer
          • Prostate cancer
          • Endometrial cancer
          • Other cancers
          • All tests
    • (sidebar parent)
      • TESTS BY SPECIALTY
        • Oncology
        • Urology
        • Imaging
        • OB/GYN
        • Mental Health
        • Internal/Primary care
        • All tests
      • TESTS BY NAME
        • BRACAnalysis CDx®
        • EndoPredict®
        • Foresight®
        • GeneSight®
        • MyChoice® CDx
        • MyRisk™ (cancer treatment)
        • MyRisk™ (cancer risk)
        • Prequel®
        • Precise™ Tumor
        • Prolaris®
  • About Myriad
    • Who we are
      • Our science & innovation
      • Corporate & social responsibility
    • Latest news
      • Myriad Genetics Blog
    • Corporate information
      • Our leadership
      • Patient advocacy partners
      • Investor relations
      • Careers
ORDER
    Order
  • Patients
    • I need help with…
      • Understanding hereditary cancer riskWhat is my risk of developing hereditary cancer?
      • Treating cancerWhat are my treatment options?
      • Prenatal careIs my baby at risk for a genetic condition?
      • Managing mental healthHow might my genes affect my medication outcomes?
    • (sidebar parent)
      • About genetic testing
        • What are the costs of genetic testing?
        • Financial assistance
      • Patient Resources
        • How does genetic testing work?
        • Patient record request
      • Prostate Cancer
        • What are my treatment options?
  • Providers
    • My patient needs a test for…
      • Assessing hereditary cancer riskWhat is my patient’s risk of developing hereditary cancer?
      • Cancer treatmentWhat is the best treatment for my patient?
      • Prenatal careWhat is a pregnancy’s risk of genetic disease?
      • Mental health treatmentHow will my patient metabolize or respond to certain medications?
    • (sidebar parent)
      • About our tests
        • Myriad test catalog
        • Research & whitepapers
        • MyRisk™ gene table
      • Provider resources
        • Order a test
        • Documents & forms
        • Scope of service & lab certificates
      • Prostate Cancer Treatment
        • What are my patient’s treatment options?
  • Our Tests
    • Tests for…
      • (column wrapper)
        • Prenatal care
          • Chromosome conditions
          • Genetic diseases
        • Cancer risk assessment
          • Hereditary cancer
        • Mental health
          • Depression
          • Anxiety
          • ADHD
      • (column wrapper)
        • Cancer management
          • Breast cancer
          • Ovarian cancer
          • Pancreatic cancer
          • Prostate cancer
          • Endometrial cancer
          • Other cancers
          • All tests
    • (sidebar parent)
      • TESTS BY SPECIALTY
        • Oncology
        • Urology
        • Imaging
        • OB/GYN
        • Mental Health
        • Internal/Primary care
        • All tests
      • TESTS BY NAME
        • BRACAnalysis CDx®
        • EndoPredict®
        • Foresight®
        • GeneSight®
        • MyChoice® CDx
        • MyRisk™ (cancer treatment)
        • MyRisk™ (cancer risk)
        • Prequel®
        • Precise™ Tumor
        • Prolaris®
  • About Myriad
    • Who we are
      • Our science & innovation
      • Corporate & social responsibility
    • Latest news
      • Myriad Genetics Blog
    • Corporate information
      • Our leadership
      • Patient advocacy partners
      • Investor relations
      • Careers

Blog

Blog
  • Category
    • All
    • clinical
    • Counsyl Complete
    • Counsyl Culture
    • Engineering, Design and Analytics
    • Events
    • Genomics and Genetic Counseling
    • Human Understanding
    • News
    • Patients
    • Product
    • Reproductive Health
    • Stories
    • Uncategorized

NAVIGATING YOUR BREAST AND OVARIAN HEALTH IN THE (NEVER-ENDING) ERA OF COVID

March 17, 2021

It has been almost a year since most of us found ourselves in the completely unchartered territory of “sheltering in place” because of the rapid spread of C...

Continue Reading

I Am Glad to Know: The Importance of Carrier Screening Through the Voice of a Carrier

February 25, 2021

This Sunday, February 28th, is #RareDiseaseDay! To raise awareness and support for the rare disease community, Myriad Women’s Health partnered with Taylor Kan...

Continue Reading

Myriad’s 7 Greatest Hits in 2020

December 23, 2020

Before we say goodbye to 2020, we’d like to thank and recognize our partners. Together, we ensure patients have access to the transformative genetic insights ...

Continue Reading

Knowledge is Power: How PKU Affected the Ahern Family

December 4, 2020

December 3rd is National PKU Day. PKU, short for phenylketonuria, is an inherited genetic condition in which the body cannot properly process the amino acid ph...

Continue Reading

Simplify Patient Identification

November 3, 2020

Streamlining Cancer Risk Assessment with Digital Tools November is Family Health History Month and is a good time to bring awareness to the importance of collec...

Continue Reading

Honoring Evan’s Memory: Raising Awareness About Tay-Sachs Disease

September 22, 2020

When I gave birth to my first child, Evan, in August of 1994, my husband Jeff and I were elated. After nine long months of anticipation, we were finally bles...

Continue Reading

New York Photographer’s Connection to Breast Cancer Helps Shape Myriad’s New Message of Human Understanding

August 26, 2020

Meet Katie McCurdy*. She is a talented photographer who has traveled the world to create vibrant, expressive images that capture authentic and intimate m...

Continue Reading

Integrating Genetic Testing into a Telehealth Program

June 30, 2020

Introducing Human Understanding a new podcast series from Myriad Women's Health. Each episode highlights real stories of providers in our communities who are m...

Continue Reading

Remote Solutions to Assess Reproductive Risk

June 16, 2020

In March, ASRM recommended that fertility care providers delay any but the most urgent reproductive care cases to mitigate the spread of the COVID-19 virus1. W...

Continue Reading

Telemedicine is not the future, it is NOW

June 10, 2020

Introducing Human Understanding a new podcast series from Myriad Women's Health. Each episode highlights real stories of providers in our communities who are m...

Continue Reading

Planning a Pregnancy in the Post-COVID-19 World

June 4, 2020

“Plans are nothing, planning is everything.” - Dwight D. Eisenhower The start of the COVID-19 pandemic certainly disrupted daily life for most of the world....

Continue Reading

Re-creating Patient /Provider Interaction: Telemedicine, The Next Frontier

May 28, 2020

Introducing Human Understanding a new podcast series from Myriad Women's Health. Each episode highlights real stories of providers in our communities who are m...

Continue Reading

Virtual Risk Assessment and Patient Education Can Help Limit In-Person Exposure

May 14, 2020

In order to adapt to the changing healthcare environment and patients’ needs, Myriad has expanded its patient education services to support patients at home....

Continue Reading

Supporting you and your patients through uncertain times

May 5, 2020

Over the past several weeks, incredible efforts have been made by healthcare professionals all over the world in response to the COVID-19 pandemic.  While...

Continue Reading

Integrating Genetic Testing into a Telehealth Program

April 29, 2020

Dr. Candace Westgate*, an OB/GYN physician in California, explains her recent experience incorporating genetic testing through virtual visits into her practice...

Continue Reading
  • 1
  • 2
  • 3
  • 4
  • 7
  • 8
  • Managed care
    • Payers
  • Investors
    • Investor relations
  • News
    • Press releases
    • Myriad Genetics’ Blog
  • About
    • Careers
    • Contact us
  • Terms of Use
  • Myriad Genetics, Inc. Privacy Policy
  • Notice of Privacy Practices
  • Language Assistance
  • Cookie Preferences
facebook linkedin twitter instagram youtube

Health. Illuminated.

  • © 2023 Myriad Genetics, Inc.